Expert Review of Hematology, Volume 10, Issue 12 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 10, Issue 12 (2017)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Volume 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Special Report

Article
Acute hemophilic hemarthrosis: is local cryotherapy recommended?
E. Carlos Rodriguez-Merchan & Hortensia De la Corte-Rodriguez
Pages: 1029-1032
Published online: 20 Oct 2017
AbstractforAcute hemophilic hemarthrosis: is local cryotherapy recommended? | Full Text | References | PDF (425.1 KB)
  • 138 Views
  • 4 CrossRef citations
  • 0Altmetric

Drug Profile

Article
Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia
Marlise R. Luskin & Daniel J. DeAngelo
Pages: 1033-1045
Published online: 30 Oct 2017
AbstractforMidostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia | Full Text | References | PDF (977.8 KB)
  • 609 Views
  • 13 CrossRef citations
  • 0Altmetric

Review

Review
Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma
Vincent Camus & Hervé Tilly
Pages: 1047-1055
Published online: 16 Nov 2016
AbstractforManaging early failures with R-CHOP in patients with diffuse large B-cell lymphoma | Full Text | References | PDF (825.2 KB)
  • 475 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia
Josep-Maria Ribera
Pages: 1057-1067
Published online: 01 Nov 2017
AbstractforEfficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia | Full Text | References | PDF (901.9 KB)
  • 895 Views
  • 30 CrossRef citations
  • 0Altmetric
Review
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia
Idanna Innocenti, Francesco Autore, Raffaella Pasquale, Francesca Morelli, Dimitar G Efremov & Luca Laurenti
Pages: 1069-1076
Published online: 03 Nov 2017
AbstractforTreatment approach for elderly and unfit patients with chronic lymphocytic leukemia | Full Text | References | PDF (642.9 KB)
  • 318 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Personalized treatment strategies for elderly patients with myelodysplastic syndromes
Roberto Castelli, Luigi Bergamaschini, Riccardo Schiavon & Giorgio Lambertenghi-Deliliers
Pages: 1077-1086
Published online: 01 Nov 2017
AbstractforPersonalized treatment strategies for elderly patients with myelodysplastic syndromes | Full Text | References | PDF (1,012.5 KB)
  • 280 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait
Rakhi P. Naik & Vimal K. Derebail
Pages: 1087-1094
Published online: 30 Oct 2017
AbstractforThe spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait | Full Text | References | PDF (651.3 KB)
  • 311 Views
  • 36 CrossRef citations
  • 0Altmetric
Review
Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia
Vincenzo De Sanctis, Ashraf T. Soliman, Heba Elsedfy, Salvatore Di Maio, Duran Canatan, Nada Soliman, Mehran Karimi & Christos Kattamis
Pages: 1095-1106
Published online: 02 Nov 2017
AbstractforGonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia | Full Text | References | PDF (1.2 MB)
  • 185 Views
  • 12 CrossRef citations
  • 0Altmetric

Original Research

Article
Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States
Andrzej J. Jakubowiak, Ivan Houisse, István Májer, Ágnes Benedict, Marco Campioni, Sumeet Panjabi & Sikander Ailawadhi
Pages: 1107-1119
Published online: 30 Nov 2017
AbstractforCost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States | Full Text | References | PDF (1.3 MB)
  • 497 Views
  • 17 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?
Varsha Bhat et al.
Report | Published online: 5 Jul 2024
Update on iron supplementation in patients with cancer-related anemia
George M. Rodgers
Review Article | Published online: 2 Jul 2024
The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms
Sigbjørn Berentsen et al.
Review Article | Published online: 28 Jun 2024
Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges
Chathuri Abeyakoon et al.
Review Article | Published online: 27 Jun 2024
View all latest articles